Michael John Rance
Directeur/Bestuurslid bij MNLpharma Ltd.
Profiel
Michael John Rance is a Non-Executive Director at MNLpharma Ltd.
since 2005.
He previously held positions as a Non-Executive Director at Medical Marketing International Group Plc, Vice President-Corporate Affairs at AstraZeneca PLC, and Principal at Reckitt & Colman Plc and AstraZeneca, Inc.
Actieve functies van Michael John Rance
| Bedrijven | Functie | Begin |
|---|---|---|
MNLpharma Ltd.
 MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Directeur/Bestuurslid | 21-02-2005 |
Eerdere bekende functies van Michael John Rance
| Bedrijven | Functie | Einde |
|---|---|---|
Medical Marketing International Group Plc
 Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 19-09-2007 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
| Reckitt & Colman Plc | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Medical Marketing International Group Plc
Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Health Services |
MNLpharma Ltd.
MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Health Technology |
| Reckitt & Colman Plc | Commercial Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |